- Home
- SOHO vs EDSA Comparison
SOHO vs EDSA Comparison
Compare SOHO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- EDSA
- Stock Information
- Founded
- SOHO 2004
- EDSA 2015
- Country
- SOHO United States
- EDSA Canada
- Employees
- SOHO N/A
- EDSA N/A
- Industry
- SOHO Real Estate Investment Trusts
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- EDSA Health Care
- Exchange
- SOHO Nasdaq
- EDSA Nasdaq
- Market Cap
- SOHO 15.4M
- EDSA 13.8M
- IPO Year
- SOHO 2004
- EDSA N/A
- Fundamental
- Price
- SOHO $0.87
- EDSA $2.12
- Analyst Decision
- SOHO Hold
- EDSA Strong Buy
- Analyst Count
- SOHO 1
- EDSA 2
- Target Price
- SOHO $1.50
- EDSA $13.00
- AVG Volume (30 Days)
- SOHO 43.0K
- EDSA 14.2K
- Earning Date
- SOHO 08-12-2025
- EDSA 08-08-2025
- Dividend Yield
- SOHO N/A
- EDSA N/A
- EPS Growth
- SOHO N/A
- EDSA N/A
- EPS
- SOHO N/A
- EDSA N/A
- Revenue
- SOHO $182,158,199.00
- EDSA N/A
- Revenue This Year
- SOHO $13.93
- EDSA N/A
- Revenue Next Year
- SOHO N/A
- EDSA N/A
- P/E Ratio
- SOHO N/A
- EDSA N/A
- Revenue Growth
- SOHO 3.11
- EDSA N/A
- 52 Week Low
- SOHO $0.59
- EDSA $1.55
- 52 Week High
- SOHO $1.54
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- SOHO 44.07
- EDSA 54.22
- Support Level
- SOHO $0.94
- EDSA $2.03
- Resistance Level
- SOHO $1.04
- EDSA $2.12
- Average True Range (ATR)
- SOHO 0.09
- EDSA 0.10
- MACD
- SOHO -0.02
- EDSA 0.01
- Stochastic Oscillator
- SOHO 18.52
- EDSA 68.97
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.